Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Authors: Lawrence, Mitchell G., Obinata, Daisuke, Sandhu, Shahneen, Selth, Luke A., Wong, Stephen Q., Porter, Laura H., Lister, Natalie, Pook, David, Pezaro, Carmel J., Goode, David L., Rebello, Richard J., Clark, Ashlee K., Papargiris, Melissa, Van Gramberg, Jenna, Hanson, Adrienne R., Banks, Patricia, Wang, Hong, Niranjan, Birunthi, Keerthikumar, Shivakumar, Hedwards, Shelley, Huglo, Alisee, Yang, Rendong, Henzler, Christine, Li, Yingming, Lopez-Campos, Fernando, Castro, Elena, Toivanen, Roxanne, Azad, Arun, Bolton, Damien, Goad, Jeremy, Grummet, Jeremy, Harewood, Laurence, Kourambas, John, Lawrentschuk, Nathan, Moon, Daniel, Murphy, Declan G., Sengupta, Shomik, Snow, Ross, Thorne, Heather, Mitchell, Catherine, Pedersen, John, Clouston, David, Norden, Sam, Ryan, Andrew, Dehm, Scott M., Tilley, Wayne D., Pearson, Richard B., Hannan, Ross D., Frydenberg, Mark, Furic, Luc, Taylor, Renea A., Risbridger, Gail P.

Source: In European Urology November 2018 74(5):562-572

Recruitment of Human C1 Esterase Inhibitor Controls Complement Activation on Blood Stage Plasmodium falciparum Merozoites

Authors: Kennedy, Alexander T., Wijeyewickrema, Lakshmi C., Huglo, Alisee, Lin, Clara, Pike, Robert, Cowman, Alan F., Tham, Wai-Hong

Source: Journal of immunology. 198(12):4728-4737

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN611784270&indx=1&recIds=ETOCRN611784270